3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Myocardial Ischemia
Myocardial ischemia is a medical condition characterized by reduced blood flow to the heart muscle, usually due to the obstruction or narrowing of coronary arteries. This restriction in blood supply deprives the heart muscle of oxygen and vital nutrients, leading to potential damage or cell death. The most common cause of myocardial ischemia is atherosclerosis, where the arteries become narrowed by the buildup of fatty deposits, cholesterol, and other substances. The condition can manifest with symptoms such as chest pain or discomfort, known as angina, and in severe cases, it can result in a heart attack. Timely diagnosis and intervention are crucial to managing myocardial ischemia and preventing further complications, emphasizing the importance of lifestyle modifications, medication, and, in some cases, surgical interventions to restore blood flow and preserve heart function.
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United KingdomSubmit your abstract Today
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain